To clarify these apparent discrepancies on the role of IRF6 and GRHL3 in cancer, we screened breast, colon, lung, and skin cancer cell lines for IRF6, GRHL3, and CDH1 transcripts and compared their levels to them in corresponding control cell lines by qPCR. This evidence concerns the gene GRHL3 and skin neoplasm.